# Kyphosis Market

> Kyphosis Market Research Report Information By Type (Postural Kyphosis, Scheuermann's Kyphosis, Congenital Kyphosis), Diagnostic Test & Diseases (X-ray, Biopsy, Aspirin, Ibuprofen, Naproxen, Spinal Fusion), End User (Hospitals, Diagnostic Centres, Research Organizations) - Forecast till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.67%
- **2024:** $ 1,308.79 Million
- **2025:** $ 1,411.08 Million
- **2035:** $ 2,674.3 Million
- **Key Players:** Medtronic (US), Stryker (US), DePuy Synthes (US), Zimmer Biomet (US), NuVasive (US), Globus Medical (US), Amedica Corporation (US), Orthofix Medical (US), K2M Group Holdings (US)

**Report ID:** MRFR/MED/1228-HCR · **Pages:** 90 · **Author:** Satyendra Maurya & Kinjoll Dey · **Last Updated:** April 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/kyphosis-market-1760

---

## Market Summary

## **Kyphosis Market Overview**

The kyphosis market is projected to reach USD 0.83 Billion by 2032 at 6.3% CAGR during the forecast period 2023-2032. The global kyphosis treatment market is estimated to gain substantial market revenue and growth in the upcoming forecasted years especially during the ongoing forecast period.

The global treatment trends help to understand the increasing prevalence of osteoporosis and recognize it as the driving force for kyphosis market operations and growth.

There has been a propelling demand for the global Kyphosis treatment market and the same is expected to reach an excellent stage especially during the ongoing forecast period. The global demand for the treatment has increased significantly because of the increasing prevalence of Kyphosis followed by the rising healthcare expenditure which will boost the market growth as per the predictions that have been laid for the ongoing forecast period.

Moreover, the increasing research and development by prominent market players will create new opportunities in the kyphosis market.

Kyphosis, as a major focus of the global market, can be understood as a condition in which the upper back gets rounded. This condition is also popularly known as the round back. It is a common problem that tends to occur during adolescence, and it occurs at any age. Wrong sitting posture is known to be the primary cause of the disease. In some cases, it doesn’t require treatment and can be cured through natural processes like yoga and exercise.

**COVID 19 Analysis**

The sudden arrival, spread, and the outbreak of the novel coronavirus pandemic have created an endless number of issues for the market players that are playing a major role in the expansion of the kyphosis market that was projected by the business chiefs that have been set for the ongoing forecast period.

The outbreak of the pandemic has been giving rise to the demand for medical emergencies to treat the patients that have tested positive for the virus. The lockdown followed by the virtual working and online classes is hampering the posture of students and giving rise to the risks that give rise to the issues like a rounded back or kyphosis in other words.

The disruptions introduced by the pandemic have been such that the treatment is not available as the medical professionals are dedicated to treating the patients that have tested positive for the virus.

The rise in the research and development followed by the investments that are on the way for the development of vaccines for different infection variants and, for the treatment of the rounded back or kyphosis. The ongoing period has a positive approach for the market as the investments are increasing rapidly.

## **Kyphosis Market Dynamics**

### **Kyphosis Market Drivers**

The Kyphoplasty devices as a prominent inclusion of the global market are expected to exhibit significant growth, and the main reason behind this is the changing lifestyle of people. The other driving factors for the global market are the adaptation of a sedentary lifestyle by the people that have led to physical inactivity, which involves high complications and a higher degree of risk. Even in patients with [osteoporosis](../../../reports/osteoporosis-drugs-market-2479) and osteopenia, physical exercise helps in reducing various kinds of risks of vertebral fractures. All these factors play an important role in developing the kyphosis market share during the ongoing forecast period.

### **Kyphosis Market Restraints**

However, the global market share is likely to witness the development of restraints that might hamper the market’s ability to meet the projected market growth. The emergence of market factors like the clearance of the products related to vertebroplasty and kyphoplasty by regulatory bodies is expected to obstruct the projected market growth during the forecast period. Also, there has been a dearth of awareness and limited treatment options that will hamper the market growth.

Technology and the rise of scientific developments in the medical field have a prominent role to play in helping to expand the market size and share of the kyphosis market during the forecast period. The global market highlights the technological expansions that are a result of the investments followed by the scientific approach and management will help the market grow and provide better aspects to the market investors.

## **Kyphosis Market Segment Overview**

The Kyphosis treatment market is segmented based on different aspects to meet the rising needs of the global target audience. The global market has been segmented based on the sub-heads like type, diagnostic test, treatment, and end-users. The growth of the global market among segments helps the market investors analyze niche pockets of growth and strategies to approach the market and determine the core application areas and the difference in the regional target markets.

### **Kyphosis Market Based on the type**

The Kyphosis market is segmented based on the type into postural kyphosis, Scheuermann's kyphosis, and congenital kyphosis.

### **Kyphosis Market Based on the diagnostic test**

The kyphosis treatment market is segmented based on the diagnostic test into imaging, biopsy, and others.

### **Kyphosis Market Based on the treatment**

The kyphosis market is segmented based on the treatment into medications, surgery, and bracing.

### **Kyphosis Market Based on the end-user**

The global kyphosis market is segmented into hospitals, clinics, ambulatory surgical centers,, and others.

## **Kyphosis Market Regional Analysis**

Countries that are covered in the discussion of the global Kyphosis market report are the U.S., Canada, Mexico in the North American region, followed by the other ones like Brazil, Argentina, Peru, Rest of South America, as part of the Southern American region, Germany, France, the United Kingdom and many more.

The market also extends its functions Est of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, followed by the rest of the Asian Pacific region. The market is extended to Saudi Arabia, the U.A.E, Egypt, Israel, Kuwait, South Africa, the Rest of the Middle East and Africa, and as a part of the Middle East and African region.

The North American region accounts for the largest market share due to the increasing prevalence of kyphosis and the growing patient population. The European region accounts for the second largest market share due to large healthcare expenditure and increasing genetic disorders.

Also, the Asian Pacific region is expected to account for the third-largest market share over coming years for the Kyphosis market due to the increasing geriatric population, especially during the ongoing forecast period.

## **Kyphosis Market Competitive Landscape**

The major players covered in the Kyphosis market are as follows:

- Amneal Pharmaceuticals LLC
- [**Zimmer Biomet**](https://investor.zimmerbiomet.com/news-and-events/news/2017/10-25-2017-123045177)
- Aurobindo Pharma Limited
- Teva Pharmaceuticals USA, Inc.
- Braun Melsungen AG
- Stryker Corporation
- Integra LifeSciences
- Perrigo Company
- Integra Lifesciences Holdings Corporation
- Orthofix Holdings, Inc.
- Johnson and Johnson
- NuVasive, Inc.
- Medtronic
- MicroPort Scientific Corporation

**Recent Developments**

According to the information that has been circulated by the American Association of Neurological Surgeons, around 75,000 people are experiencing vertebral compression fractures every year. For instance, recently the prominent company - Merit Medical introduced two products for vertebral compression fracture, ‘Diamond TOUCH’ and ‘Stability’.

The syringe as a treatment has the capability of injecting cement as well as inflating and deflating the interventional devices. Hence, this is a major market factor that is expected to boost the demand for the vertebroplasty and kyphoplasty markets.

The growing prevalence of vertebral compression fracture, and according to the study of Osteoporosis International, in 2017, around 30% - 50% of people worldwide had witnessed a vertebral compression fracture.

Also, according to the study of the Journal of Spine Surgery published in 2019, the kyphoplasty treatment that was performed for vertebral height restoration showed significant outcomes. Therefore, these prominent market factors are expected to propel the growth of the vertebroplasty and kyphoplasty market in this segment.

**Report Overview**

The kyphosis market research report has been prepared after studying the core market competencies and dynamics that are available for the ongoing forecast period. The global market report highlights the market challenges like coronavirus and others and the patterns that the regional players are following to convert the challenges into market opportunities for futuristic expansion. The report also helps to understand the market segmentation and rising competition with each passing day.

## Market Drivers

### Rising Geriatric Population

The Global Kyphosis Market Industry is significantly influenced by the rising geriatric population, as older adults are more susceptible to spinal deformities. With advancements in healthcare, life expectancy is increasing, leading to a larger demographic of elderly individuals. This population often experiences conditions such as osteoporosis, which can exacerbate kyphosis. Consequently, the demand for effective treatment options is expected to rise, further propelling market growth. As healthcare systems adapt to cater to this demographic, the market is likely to see an increase in specialized services and products tailored to the needs of older patients.

### Growing Awareness and Education

There is a notable increase in awareness and education regarding kyphosis and its implications on overall health within the Global Kyphosis Market Industry. Healthcare campaigns and community outreach programs are effectively informing the public about the importance of early diagnosis and treatment. This heightened awareness is likely to lead to more individuals seeking medical advice and intervention, thereby driving market growth. Educational initiatives targeting both healthcare professionals and patients are crucial in fostering a better understanding of kyphosis, which may contribute to improved treatment rates and outcomes.

### Increasing Prevalence of Kyphosis

The Global Kyphosis Market Industry is experiencing growth due to the rising prevalence of kyphosis among various age groups. Factors such as aging populations and sedentary lifestyles contribute to the increasing incidence of spinal deformities. In 2024, the market is valued at 0.27 USD Billion, reflecting a growing awareness of spinal health. As more individuals seek treatment options, the demand for medical devices and therapies is expected to rise, potentially leading to a market valuation of 1.0 USD Billion by 2035. This trend indicates a compound annual growth rate (CAGR) of 12.68% from 2025 to 2035.

### Advancements in Treatment Technologies

Technological advancements in treatment modalities are propelling the Global Kyphosis Market Industry forward. Innovations in surgical techniques, such as minimally invasive procedures and improved spinal implants, enhance patient outcomes and reduce recovery times. These advancements not only attract more patients but also encourage healthcare providers to adopt new technologies. The integration of robotics and artificial intelligence in surgical planning and execution further optimizes treatment efficacy. As a result, the market is poised for substantial growth, with a projected increase in demand for advanced treatment options over the coming years.

### Regulatory Support and Reimbursement Policies

Regulatory support and favorable reimbursement policies are playing a pivotal role in shaping the Global Kyphosis Market Industry. Governments and health organizations are increasingly recognizing the need for comprehensive treatment options for spinal deformities. As a result, policies that facilitate access to care and reimbursement for kyphosis treatments are being implemented. This support encourages healthcare providers to offer innovative solutions and enhances patient access to necessary therapies. The positive regulatory environment is expected to stimulate market growth, as more individuals can seek timely and effective treatment for kyphosis.

## Future Outlook

The Kyphosis Market is projected to grow at a 6.67% CAGR from 2025 to 2035, driven by increasing awareness, technological advancements, and an aging population.

**New opportunities:**

- Development of advanced spinal braces utilizing smart technology. Expansion of telehealth services for remote patient monitoring. Investment in regenerative medicine for kyphosis treatment solutions.

By 2035, the Kyphosis Market is expected to achieve substantial growth, reflecting evolving healthcare needs.

## Segment Insights

### By Application: Surgical Treatment (Largest) vs. Non-Surgical Treatment (Fastest-Growing)

In the Kyphosis Market, the application segment is primarily divided into four key areas: Surgical Treatment, Non-Surgical Treatment, Physical Therapy, and Medication. Surgical Treatment commands the largest share, owing to its effectiveness in addressing severe kyphosis cases. On the other hand, Non-Surgical Treatment is quickly gaining traction, appealing to patients who prefer less invasive options. This split showcases the diversity in treatment approaches within the market, reflecting varying patient needs and preferences. The growth trends in this segment are influenced by the increasing aging population and the rising prevalence of kyphosis-related complications. Furthermore, advances in minimally invasive surgical techniques are driving the popularity of Surgical Treatment, while a greater emphasis on preventive care promotes the use of Non-Surgical Treatment. This dynamic landscape indicates a shift towards more patient-centered treatment choices, with both segments contributing significantly to market expansion.

Surgical Treatment (Dominant) vs. Non-Surgical Treatment (Emerging)

Surgical Treatment stands out as the dominant approach in the Kyphosis Market, particularly for patients with severe spinal deformities. Characterized by its effectiveness in correcting spinal alignment and alleviating pain, this method is often recommended when non-invasive measures fail. The advancements in surgical techniques, including minimally invasive options, have enhanced patient outcomes and reduced recovery times, further solidifying its position. Conversely, Non-Surgical Treatment is emerging rapidly, driven by a growing demand for less invasive solutions. Options such as physical therapy, medication, and lifestyle modifications are increasingly popular among patients seeking to manage symptoms and improve quality of life. The push for holistic, patient-centered care indicates a promising future for Non-Surgical Treatment as awareness and education about these options expand.

### By End Use: Hospitals (Largest) vs. Rehabilitation Centers (Fastest-Growing)

In the Kyphosis Market, the distribution of end use segments reveals that hospitals hold the largest share due to their extensive resources and specialized care for kyphosis patients. Clinics represent a significant portion of the market as well, providing essential outpatient services. Rehabilitation centers are gaining ground, particularly as awareness of postural issues has risen. Home care is gradually becoming more relevant in the market, especially with the increasing emphasis on personalized healthcare services for patients recovering from kyphosis treatments.

Hospitals (Dominant) vs. Rehabilitation Centers (Emerging)

Hospitals serve as the dominant force in the Kyphosis Market, equipped with advanced medical technologies and a comprehensive range of treatment options, including surgical interventions and rehabilitation programs. Their extensive infrastructure allows for effective management of complex cases, making them a preferred choice for many patients. On the other hand, rehabilitation centers are emerging as a vital component in the overall care continuum for kyphosis, focusing on post-operative recovery and symptom management. These centers cater to a growing population that seeks specialized rehabilitation services, leveraging personalized treatment plans and therapies. This shift in focus towards rehabilitation underscores the evolving landscape of the Kyphosis Market.

### By Type of Kyphosis: Postural Kyphosis (Largest) vs. Scheuermann's Kyphosis (Fastest-Growing)

In the Kyphosis Market, Postural Kyphosis holds the largest share due to its prevalence among adolescents and adults who experience slumping and poor posture over time. This type, often corrected through physical therapy and lifestyle modifications, accounts for a significant segment of patients seeking treatment. In contrast, Scheuermann's Kyphosis, characterized by a more rigid spinal deformity that commonly arises during adolescence, shows rapid growth in market interest as awareness of spinal health increases among younger populations and preventative measures gain traction.

Postural Kyphosis (Dominant) vs. Scheuermann's Kyphosis (Emerging)

Postural Kyphosis is recognized for being the dominant form of kyphosis, typically resulting from lifestyle factors such as prolonged sitting and poor ergonomics. Its characteristics include flexibility and the potential for rehabilitation through exercise and awareness campaigns. On the other hand, Scheuermann's Kyphosis is an emerging category, defined by a structural abnormality of the spine that could lead to additional complications if left untreated. This type attracts growing attention from healthcare providers and patients alike, as its early identification and treatment can lead to improved outcomes. The increasing focus on adolescent spine health and preventative measures positions Scheuermann's Kyphosis as a significant area of concern within the market.

### By Age Group: Adults (Largest) vs. Children (Fastest-Growing)

In the Kyphosis Market, the age group of adults represents the largest segment, predominantly due to the prevalence of kyphosis in this demographic. Factors contributing to this include degenerative changes associated with aging and conditions such as osteoporosis, which are more common in adults. Moreover, the growing awareness and diagnosis of spinal deformities in adults have led to an increased market share for treatments and interventions tailored to this group. Conversely, the children segment is emerging as the fastest-growing demographic in the Kyphosis Market. This growth can be attributed to the rising incidence of adolescent kyphosis, often due to postural issues and increased sedentary behavior in younger populations. The focus on education and preventive measures regarding spinal health in schools is also contributing to the growth of this segment, promoting earlier diagnosis and treatment options for children and adolescents.

Adults (Dominant) vs. Children (Emerging)

The adults segment in the Kyphosis Market remains dominant due to a larger patient population, largely influenced by age-related spinal changes and lifestyle factors. Adults often seek various treatment options, such as physical therapy, braces, and surgical interventions, reflecting a matured engagement with the healthcare system. On the other hand, children represent an emerging segment; the increasing prevalence of postural kyphosis linked to modern lifestyle choices has sparked growing concern among parents and healthcare professionals. This has resulted in a pivotal focus on awareness campaigns and early treatment initiatives. The need for specialized pediatric care and the growing understanding of juvenile orthopedic conditions positions children as a critical market segment that could drive future growth.

### By Severity Level: Moderate Kyphosis (Largest) vs. Severe Kyphosis (Fastest-Growing)

The Kyphosis Market is segmented by severity levels including Mild, Moderate, and Severe Kyphosis. In terms of market share distribution, Moderate Kyphosis represents the largest segment among these due to its higher prevalence and recognition in clinical settings. Patients suffering from Moderate Kyphosis often seek treatments such as physical therapy and corrective surgeries, contributing to a robust demand in this segment. Conversely, Severe Kyphosis, while smaller in market share, is gaining traction as awareness grows around the severity of its impact and treatment options available. As healthcare providers increasingly focus on severe conditions, this segment is witnessing substantial attention. Looking at growth trends, Moderate Kyphosis continues to benefit from established treatment protocols and a steady influx of patients, ensuring its dominance in the market. On the other hand, Severe Kyphosis is emerging as a critical area for growth due to rising rates of diagnosis and the development of advanced therapeutic interventions. Factors contributing to this growth include an aging population that is more prone to spinal issues, as well as enhanced healthcare technologies that provide improved outcomes. With increased research and advancements, Severe Kyphosis is set to capture a larger share of the market in the coming years.

Moderate Kyphosis (Dominant) vs. Severe Kyphosis (Emerging)

Moderate Kyphosis, being the dominant segment in the Kyphosis Market, consists of individuals widely seeking clinical intervention due to its noticeable impacts on health and lifestyle. This segment is characterized by its range of treatment options that are widely accepted and readily available, including non-surgical methods such as physiotherapy and surgical interventions for more pronounced cases. In contrast, Severe Kyphosis is regarded as an emerging segment that focuses on patients with extreme curvature and severe symptoms necessitating urgent medical attention. With advancing medical technologies and an emphasis on better patient outcomes, the Severe Kyphosis segment is progressively gaining recognition, pushing healthcare systems to develop specialized treatment solutions to cater to this critical condition.

## Regional Market Share Analysis

### North America : Market Leader in Kyphosis Care

North America is poised to maintain its leadership in the Kyphosis market, holding a significant market share of $650.0M as of 2024. The region's growth is driven by an aging population, increasing prevalence of spinal disorders, and advancements in surgical techniques. Regulatory support for innovative medical devices further fuels demand, ensuring a robust market environment. The focus on minimally invasive procedures is also a key trend, enhancing patient outcomes and driving market expansion. The competitive landscape in North America is characterized by the presence of major players such as Medtronic, Stryker, and DePuy Synthes. These companies are at the forefront of innovation, offering a range of products tailored to treat Kyphosis. The U.S. remains the leading country, supported by a well-established healthcare infrastructure and significant investment in research and development. This competitive edge positions North America as a hub for advancements in Kyphosis treatment.

### Europe : Emerging Market with Growth Potential

Europe's Kyphosis market is projected to grow significantly, with a market size of $350.0M. Key growth drivers include an increasing elderly population, rising awareness of spinal health, and advancements in medical technology. Regulatory frameworks in the EU are becoming more supportive of innovative treatments, which is expected to enhance market dynamics. The focus on patient-centered care and improved surgical outcomes is also contributing to the market's expansion. Leading countries in Europe include Germany, France, and the UK, where healthcare systems are increasingly adopting advanced spinal treatments. The competitive landscape features key players like Zimmer Biomet and Globus Medical, who are investing in R&D to develop cutting-edge solutions. The presence of strong regulatory bodies ensures that products meet high safety and efficacy standards, further driving market growth. "The European market is witnessing a surge in demand for innovative spinal treatments, reflecting a commitment to improving patient outcomes," European Spine Society.

### Asia-Pacific : Rapidly Growing Market Segment

The Asia-Pacific region is emerging as a significant player in the Kyphosis market, with a market size of $250.0M. Factors such as increasing healthcare expenditure, a growing elderly population, and rising awareness of spinal health are driving market growth. Additionally, government initiatives aimed at improving healthcare access and quality are expected to further stimulate demand for Kyphosis treatments. The region is also witnessing a shift towards advanced surgical techniques and minimally invasive procedures. Countries like Japan, China, and India are leading the market, with a growing number of healthcare facilities adopting advanced spinal treatments. The competitive landscape includes both local and international players, with companies like NuVasive and Orthofix Medical making significant inroads. The increasing collaboration between healthcare providers and manufacturers is enhancing the availability of innovative solutions, positioning Asia-Pacific as a key market for future growth.

### Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa region is gradually developing its Kyphosis market, currently valued at $58.79M. The growth is driven by increasing awareness of spinal health and the rising prevalence of spinal disorders. However, challenges such as limited healthcare infrastructure and access to advanced medical technologies hinder rapid market expansion. Regulatory bodies are beginning to implement frameworks to support the introduction of innovative treatments, which may enhance market dynamics in the future. Countries like South Africa and the UAE are at the forefront of adopting advanced spinal treatments, although the market remains fragmented. The presence of key players is limited compared to other regions, but companies are increasingly looking to invest in this market. The focus on improving healthcare access and quality is essential for the growth of the Kyphosis market in this region. "The Middle East and Africa are on the cusp of significant advancements in spinal health, driven by increasing healthcare investments," World Health Organization.

## Competitive Benchmarking

The Kyphosis Market is currently characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include an aging population, increasing prevalence of spinal disorders, and advancements in surgical techniques and technologies. Major players such as Medtronic (US), Stryker (US), and DePuy Synthes (US) are strategically positioned to leverage these trends. Medtronic (US) focuses on innovation through the development of minimally invasive surgical solutions, while Stryker (US) emphasizes partnerships with healthcare providers to enhance patient outcomes. DePuy Synthes (US) is actively pursuing mergers and acquisitions to expand its product portfolio, thereby shaping a competitive environment that is increasingly reliant on technological advancements and collaborative efforts.In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly crucial in a moderately fragmented market. This competitive structure allows for a diverse range of products and services, enabling companies to cater to specific regional needs while maintaining a global presence. The collective influence of these key players fosters an environment where innovation and operational efficiency are paramount.
In November Medtronic (US) announced the launch of a new spinal implant designed to enhance stability and reduce recovery time for kyphosis patients. This strategic move underscores Medtronic's commitment to innovation and positions the company as a leader in advanced spinal solutions. The introduction of this product is likely to strengthen Medtronic's market share and enhance its competitive edge.Similarly, in October 2025, Stryker (US) expanded its product line by acquiring a startup specializing in AI-driven surgical planning tools. This acquisition is indicative of Stryker's strategy to integrate cutting-edge technology into its offerings, potentially revolutionizing surgical procedures for kyphosis treatment. By harnessing AI, Stryker aims to improve surgical precision and patient outcomes, thereby solidifying its position in the market.
In September DePuy Synthes (US) launched a comprehensive training program for surgeons focusing on the latest techniques in kyphosis correction. This initiative not only enhances the skill set of healthcare professionals but also reflects DePuy Synthes's commitment to education and innovation in the field. By investing in surgeon training, the company is likely to foster loyalty among practitioners and improve patient care standards.
As of December current competitive trends in the Kyphosis Market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are shaping the landscape, facilitating knowledge sharing and resource optimization. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift may lead to a more sustainable and efficient market, where companies that prioritize these elements are likely to thrive.

## Recent News & Developments

According to the information that has been circulated by the American Association of [Neurological](https://www.marketresearchfuture.com/reports/neurology-devices-market-9768')Surgeons, around 75,000 people are experiencing vertebral compression fractures every year. For instance, recently the prominent company - Merit Medical introduced two products for vertebral compression fracture, ‘Diamond TOUCH’ and ‘Stability’.

The syringe as a treatment has the capability of injecting cement as well as inflating and deflating the interventional devices. Hence, this is a major market factor that is expected to boost the demand for the [vertebroplasty and kyphoplasty markets](https://www.marketresearchfuture.com/reports/vertebroplasty-kyphoplasty-market-42552).

The growing prevalence of vertebral compression fracture, and according to the study of Osteoporosis International, in 2017, around 30% - 50% of people worldwide had witnessed a vertebral compression fracture.

Also, according to the study of the Journal of Spine Surgery published in 2019, the [kyphoplasty](https://www.marketresearchfuture.com/reports/kyphoplasty-market-32684) treatment that was performed for vertebral height restoration showed significant outcomes. Therefore, these prominent market factors are expected to propel the growth of the vertebroplasty and kyphoplasty market in this segment.

## Report Scope

| MARKET SIZE 2024 | 1308.79(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 1411.08(USD Million) |
| MARKET SIZE 2035 | 2674.3(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.67% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Medtronic (US), Stryker (US), DePuy Synthes (US), Zimmer Biomet (US), NuVasive (US), Globus Medical (US), Amedica Corporation (US), Orthofix Medical (US), K2M Group Holdings (US) |
| Segments Covered | Application, End Use, Patient Demographics, Severity of Condition, Type of Kyphosis |
| Key Market Opportunities | Advancements in minimally invasive surgical techniques enhance treatment options in the Kyphosis Market. |
| Key Market Dynamics | Rising demand for minimally invasive surgical techniques drives innovation in the kyphosis treatment market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Kyphosis Market as of 2024?**
A: The Kyphosis Market was valued at 1308.79 USD Million in 2024.

**Q: What is the projected market valuation for the Kyphosis Market in 2035?**
A: The projected valuation for the Kyphosis Market in 2035 is 2674.3 USD Million.

**Q: What is the expected CAGR for the Kyphosis Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Kyphosis Market during the forecast period 2025 - 2035 is 6.67%.

**Q: Which companies are considered key players in the Kyphosis Market?**
A: Key players in the Kyphosis Market include Medtronic, Stryker, DePuy Synthes, Zimmer Biomet, and NuVasive.

**Q: What are the main segments of the Kyphosis Market by application?**
A: The main segments by application include Surgical Treatment, Non-Surgical Treatment, Physical Therapy, and Medication.

**Q: How does the valuation of Non-Surgical Treatment compare to Surgical Treatment in the Kyphosis Market?**
A: Non-Surgical Treatment was valued between 400.0 and 800.0 USD Million, whereas Surgical Treatment ranged from 300.0 to 600.0 USD Million.

**Q: What is the market valuation for different types of Kyphosis?**
A: The market valuations for types of Kyphosis range from 200.0 to 700.0 USD Million, with Degenerative Kyphosis valued between 458.79 and 974.3 USD Million.

**Q: What are the end-use segments in the Kyphosis Market?**
A: End-use segments in the Kyphosis Market include Hospitals, Clinics, Rehabilitation Centers, and Home Care.

**Q: Which age group has the highest market valuation in the Kyphosis Market?**
A: Adults have the highest market valuation, ranging from 600.0 to 1200.0 USD Million.

**Q: What are the severity levels of Kyphosis and their corresponding market valuations?**
A: Severity levels of Kyphosis include Mild, Moderate, and Severe, with valuations ranging from 261.76 to 1081.72 USD Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/kyphosis-market-1760*